Average down: buy more shares at lower price with the assumption CMG will one day recover and go higher.
All quality big cap stocks take dives and recover. Do you consider CMG a quality stock is subject to interpretation, so do some research. Fast food restaurants, in general, their stock price has not gone up vs S&P 500.
E.coli will bump CMG sales lower until they find the cause to never repeat - could it be the salsa?
If sales and eps go lower, CMG stock should follow under 600.
Market will look deep and find ways to depress XPO stock close to zero ($0.00).
One day it will succeed...
It is all about expectation of meeting targets...did it on revenue but not got to take out the one-time items.
If you compare against the competitors, pretty decent eps, but many will say it can't be that good when others like CHRW, ECHO, RRTS, EXPD didn't do so well.
Therefore, expect XPO shares to follow all others and go lower instead of higher.
Maybe the good times will roll in 2016-2019 as BJ projects and share price goes over 50 some day.
Target date is before turkey day...negotiating how much stock/cash allocation and succession plans for CEO when he retires.
Wild card is some other pharma company wants to bid like AZN who turned down PFE's merger (remote)
Deal merger will be completed by Thanksgiving per Barron's article.
Read will retire soon, Saunders to take over - age factor 65 vs 45.
Besides, Saunders is a visionary and sees more consolidation coming and more deals.
Price for merger - PFE will offer cash/stock for AGN worth at least $350/share.
Politicians can object to inversion but legal deal unless laws changed.
Too bad for Hillary and Obama the dictators as Congress won't go along IMO.
GLTA long and shorts (tuna)
at what target price will you sell IMMR for a profit - over 20?
IMMR too small potatoes to be around another 5 more years...bait for a larger company but at what low-ball price.
Left does not have any more juicy new items to provide - on advice of his attorneys.
Therefore, don't get too excited he will move VRX down over today.
unreal from 45.xx to over 60.xx in less than 2 weeks.
Still short-covering based on eps good news and projection or something else.
Could be rumors of someone out there kicking ABBV's tires like PFE to AGN.
I would hold for ABBV dividend.
Expect reversal ABBV stock reversal but only back to mid 50s.
ABBV with products coming out should see 70-85 by 2018.
Christmas will come early for you...depending on your target price to cover.
Cover at 80s but expecting 50s might be overdoing it on the downside even if fraud proven.
Left chickened out with no additional updates...but VRX just up a couple bucks.
Not good indicator of a dead-cat bounce.
Whatever, VRX makes for good day trading.
Shorts - don't get too greedy....longs don't expect VRX to go to 150
Creative accounting issues will crush all companies...shares will be in free-fall.
Nice while it lasted VRX going higher until the music stops.
Too many agencies have questions go unanswered...articles in LA Times, Fortune, Forbes this weekend point to fraud. Will take time to prove but sell first, ask questions later.
If you believe Ackman VRX will be rise to over 450 by 2018...high risk going long.
If true, Ackman didn't know how to spread his risk around.
Always the last trade to wipe out all the winners in the past.
What goes around comes around.
HLF must be hysterical after Ackman presentation to send it to 0 (but near its 52-week high).
However, jury is still out...maybe HLF smarter and a step ahead of grave diggers.
after his presentation VRX trades under 100.
Accounting issues will result in VRX free-fall. Trade in 90s, bounce, then 80s, 70s, under 50.
Looks like few believe Ackman's claim to hold, buy more and pray for over 400.
VRX can't buy any more pharma company with low VRX stock price.
The old AGN company was wise to take Actavis offer instead of caving in to VRX.
December of 2018 and $400...can you wait and buy more shares on the downside.
VRX might not be around by then...go single digits and do a reverse stock split 1:100 to get over 400 (lol).
HLF made a comment to Ackman...do your homework before purchase or attacking.
Can you tell us your target sell price for a profit?
Didn't expect DGI to tank this much...will it trade single digits is not good.
In 6 months and another eps report DGI should do better and trade over 20...if you can wait and pray.
Screaming buy at 100 and holding for higher price?
Or sell at 101?
Limited upside, but VRX can go free-fall at any time.
Day traders delight - wonderful stock to trade more than 10X in a day.
For 2015 ABBV stock has a negative return...watch if it can turn positive return to 65-70 target by year-end.
WSJ has an article to be out 10/30/15 the AGN offer should be at least $150B.
That translate to $380 per share.
$360 is close before the finalization - discounted for waiting.
PFE won't low ball with all the AGN perks like low tax rate, products.
BGFV stock in the past has crashed with "poor" eps.
BGFV should bounce back but nowhere over 20 - more likely 10-13 range.
BGFV is small cap & stocks in this category not doing as good as large cap in 2015.
Be on guard if BGFV still lags, management can reduce or eliminate the dividend.
Even DKS is selling near its 52-week lows.